AzTrials
AzTrials

Sexual Risk BehaviorTHRIVENCT01395979

HIV Prevention and Trauma Treatment for Men Who Have Sex With Men With Childhood Sexual Abuse Histories

A study testing Cognitive Processing Therapy for Sexual Risk, Supportive Psychotherapy and Sexual Risk Reduction Intervention in people with Sexual Risk Behavior and Childhood Sexual Abuse, run by Massachusetts General Hospital at 3 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Brief Summary: The specific aims of this study are: 1. To test, in a two-arm randomized controlled trial, the efficacy of cognitive processing therapy for sexual risk and posttraumatic symptom severity reduction (CPT-SR) in HIV-uninfected men who have sex with men (MSM) who have histories of childhood sexual abuse… Read more about this study

Who is it for?
Ages 18 years and older, men only
What is being tested?
Cognitive Processing Therapy for Sexual Risk, Supportive Psychotherapy and Sexual Risk Reduction Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
232 participants
Where
3 sitesUnited States
Study dates
Oct 2011to May 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Identifies as MSM.
  • Reports history of CSA (sexual contact before the age of 13 with an adult or person 5 years older or sexual contact with the threat of force or harm between the ages of 13 and 16 inclusive or with a person 10 years older).
  • Reports >1 episode of unprotected anal or vaginal intercourse within the past three months.
  • Reports HIV-negative status confirmed by rapid HIV test.
  • Is capable of completing and fully understanding the informed consent process and the study procedures.

Who cannot join

  • All episodes of unprotected anal or vaginal intercourse occurred with only a single, primary HIV-negative partner.
  • Significant mental health diagnosis requiring immediate treatment (e.g. bipolar disorder; any psychotic disorder).
  • Inability to complete informed consent process (e.g. substantial cognitive impairment, inadequate English language skills).
  • Has received CPT for PTSD within the past 12 months.

Trial locations and contacts

3 sites in 1 country.

United States3 sites
  • Massachusetts General Hospital

    Boston, Massachusetts, 02114-2919

  • The Fenway Institute

    Boston, Massachusetts, 02215

  • University of Miami

    Coral Gables, Florida, 33124-0751

Other trials in United States

About this study

Brief Summary: The specific aims of this study are:

  1. To test, in a two-arm randomized controlled trial, the efficacy of cognitive processing therapy for sexual risk and posttraumatic symptom severity reduction (CPT-SR) in HIV-uninfected men who have sex with men (MSM) who have histories of childhood sexual abuse (CSA). The primary outcome is reduction in unprotected anal/vaginal intercourse (number and proportion) with serodiscordant partners. The investigators will also examine the intervention effect on CSA-related trauma symptom severity and cognitions and behaviors.
  2. To examine the degree to which intervention-related reductions in sexual risk behavior are mediated by reductions in CSA-related symptom severity, cognitions, and behaviors.
  3. To examine the degree to which the intervention reduces incident sexually transmitted infections (STIs) during the study period, as well as to explore additional potential moderators and mediators of intervention efficacy.
Read more

Study hypotheses:

  1. For the primary outcome, the investigators hypothesize that those who receive the intervention will have reduced transmission-risk behavior.
  2. For the secondary outcome, the investigators hypothesize that those who receive the intervention will have reduced trauma symptom severity (cognitions and behaviors).
Read the detailed description

The prevalence of HIV among men who have sex with men (MSM) is estimated at an alarming 19% domestically (CDC 2010), rates comparable to endemic settings in certain regions of sub-Saharan Africa where approximately 20% of the adult population is HIV infected. Studies have also demonstrated a staggeringly high prevalence of childhood sexual abuse (CSA) in MSM, and shown an association between CSA and HIV risk in MSM. A successful intervention for MSM with a CSA history to prevent HIV has the potential to avert infections among some of the riskiest members of the most HIV vulnerable group in the U.S. Notwithstanding the ability of the existing HIV prevention interventions to show reductions in sexual risk taking, the recent successes of chemoprophylaxis, current policy initiatives, and empirically supported recommendations, all support development of combination prevention interventions that can specify multiple prevention targets, address related risk factors and barriers, and are grounded in a community context. The pathways from CSA to adult sexual risk behavior are varied and complex and this complexity is appropriately addressed in individual-based interventions where empirically supported interventions for CSA related trauma were efficacy tested. The development of an integrated prevention intervention that utilizes cognitive behavioral technologies to address co-occurring and interfering CSA and sexual risk represents a novel and largely untested innovative application that is theoretically designed to address sexual risk directly and indirectly through reductions in CSA-related trauma symptoms. The flexibility of integrated and combination prevention programs has the potential to support triage of MSM with particular risk profiles to the programs that best meet their prevention needs.

This two-arm RCT is designed to test the efficacy of a psycho-social intervention that addresses intersecting epidemics among MSM, HIV and CSA. The experimental condition integrates sexual risk reduction counseling with Cognitive Processing Therapy for Sexual Risk (CPT-SR). CPT-SR has been specifically piloted on MSM with CSA histories and sexual risk to reduce interfering negative CSA-related thoughts about self, to more accurately appraise sexual risk, and to decrease avoidance of sexual safety considerations through rehearsals of sexual safety behaviors. The active and time-matched comparison condition is risk reduction counseling plus supportive psychotherapy. The investigators will randomize HIV-uninfected MSM who report a history of CSA and multiple recent sexual risk episodes for HIV (unprotected anal/vaginal intercourse) across two sites (Boston and Miami). The primary outcome will be self-reported sexual risk taking as assessed via a computer-based questionnaire. Secondary outcomes include trauma symptom severity, both cognitive and behavioral. Study assessment points are at baseline, 3 (post treatment), 6, 9, and 12-month follow-ups.

Being tested
Cognitive Processing Therapy for Sexual Risk, Supportive Psychotherapy, Sexual Risk Reduction Intervention
Medical subject headings
Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive Processing Therapy for Sexual RiskBehavioural

    Also called CPT-SR

    Eight weekly sessions, 4 modules.

  • Supportive PsychotherapyBehavioural

    Also called TMC

    Eight weekly sessions

  • Sexual Risk Reduction InterventionBehavioural

    Two weekly sessions.

Study groups in NCT01395979
Study groupRoleWhat they receive
Cognitive Processing Therapy for Sexual Risk (CPT-SR)ExperimentalThe CPT-SR condition will be comprised of 10 individual therapy sessions fully integrating sexual risk reduction counseling into cognitive therapy for sexual abuse-related trauma.
Receives: Behavioral: Cognitive Processing Therapy for Sexual Risk; Behavioral: Sexual Risk Reduction Intervention
Time-Matched Control (TMC)Active comparatorThe TMC will be comprised of sexual risk reduction counseling/education and supportive psychotherapy.
Receives: Behavioral: Supportive Psychotherapy; Behavioral: Sexual Risk Reduction Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes from Baseline in Sexual Risk Behavior for HIV Acquisition

    Number of unprotected (no condom was used) insertive or receptive anal or vaginal intercourse acts reported in the past 3 months with casual partners or with partners with unknown or positive HIV status.

    Measured: Baseline, (2 weeks post-baseline pre-randomization), 3,6, 9, and 12 month follow ups

Secondary outcomes (1)
  1. Changes from Baseline in Trauma Symptom Severity

    Davidson Trauma Scale which has been correlated with measures of Post-Traumatic Stress Disorder (PTSD) severity, depression, and general anxiety, and discriminated well between traumatized individuals with and without PTSD.

    Measured: Baseline assessment, 3, 6, and 9-month follow-up assessments

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jul 2011 (estimated)
  2. Study startOct 2011
  3. Primary completionMay 2017
  4. Study completionMay 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
232 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01395979
Sponsor's protocol ID
R01MH095624-01
Acronym
THRIVE
Status last verified
Mar 2018
First submitted
11 Jul 2011
Last updated
30 Mar 2018
Results posted
No
Data monitoring committee
Yes

Publications

  • Batchelder AW, Fitch C, Feinstein BA, Thiim A, O'Cleirigh C. Psychiatric, Substance Use, and Structural Disparities Between Gay and Bisexual Men with Histories of Childhood Sexual Abuse and Recent Sexual Risk Behavior. Arch Sex Behav. 2021 Oct;50(7):2861-2873. doi: 10.1007/s10508-021-02037-1. Epub 2021 Oct 21.

    PubMed 34676467
  • Batchelder AW, Choi K, Dale SK, Pierre-Louis C, Sweek EW, Ironson G, Safren SA, O'Cleirigh C. Effects of syndemic psychiatric diagnoses on health indicators in men who have sex with men. Health Psychol. 2019 Jun;38(6):509-517. doi: 10.1037/hea0000724. Epub 2019 Apr 11.

    PubMed 30973745

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive Processing Therapy for Sexual Risk, Supportive Psychotherapy and Sexual Risk Reduction Intervention in people with Sexual Risk Behavior and Childhood Sexual Abuse, run by Massachusetts General Hospital at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Mar 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes from Baseline in Sexual Risk Behavior for HIV Acquisition (time frame: Baseline, (2 weeks post-baseline pre-randomization), 3,6, 9, and 12 month follow ups). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01395979, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in